Latest News

Friday, July 22, 2016 | Management/Leadership, Shire

Beth Marsh Joins Shire's Ophthalmics Team as Commercial Strategy Lead for Infectious Conjunctivitis Drug Candidate

Beth Marsh recently joined Shire's ophthalmics team as Commercial Strategy Lead for SHP640, the development program for a novel agent being investigated to treat infectious conjunctivitis (adenovi…

Read the full story

Friday, July 22, 2016 | Cataract Surgery, Medical Studies, Imprimis Pharmaceuticals

Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops

Imprimis Pharmaceuticals announced that positive results of a clinical study comparing the efficacy of its injected triamcinolone acetonide, moxifloxacin hydrochloride, and vancomycin (Tri-Moxi-Vanc) …

Read the full story

Friday, July 22, 2016 | Patents, Inotek Pharmaceuticals

Inotek Pharmaceuticals Expands Intellectual Property Portfolio with Combination Patent for IOP Lowering

Inotek Pharmaceuticals announced that the United States Patent and Trademark Office issued a composition of matter patent for the combination of the company’s lead product candidate, trabod…

Read the full story

Friday, July 22, 2016 | Health Care

CMS Release Proposed Medicare Fee Schedule to Impact Optometry Practices

A proposed rule for Medicare's 2017 Physician Fee Schedule contains several policies that will impact doctors of optometry participating in postoperative care, diabetes care and Medicare Advantage…

Read the full story

Friday, July 22, 2016 | Miscellaneous, Bausch+Lomb, Valeant

FDA Raises Manufacturing Concerns in Complete Response Letter for Valeant's Vesneo Eye Drop

The FDA issued a complete response letter to Valeant Pharmaceuticals in relation to its filing for Vesneo (latanoprostene bunod), an IOP-lowering single-agent eye drop for patients with open angle gla…

Read the full story

Friday, July 22, 2016 | Medical Studies

Endophthalmitis Risk Low After Intravitreal Injection

Only 30 cases of endophthalmitis occurred after 90,339 intravitreal injections, and prophylactic antibiotics did not decrease the rate of infections, a recent study suggests. Most physicians no longer…

Read the full story

Thursday, July 21, 2016 | Medical Studies, American Academy of Ophthalmology, Second Sight Medical Products

Five-Year Results of the Argus II Device Published

After 5 years, researchers say the Argus II retinal prosthesis system remains a safe and beneficial way to return functional vision to patients who are blind from retinitis pigmentosa, according to a …

Read the full story

Thursday, July 21, 2016 | Medical Studies

Detecting and Treating Glaucoma in a Myopic Patient Without High IOP

The prevalence of myopia is increasing both in the United States and worldwide. Between 1971 and 1972, the National Health and Nutrition Examination Survey (NHANES) estimated that 25% of the US popula…

Read the full story

Thursday, July 21, 2016 | Medical Studies

Is a Refractive Cataract Fellowship Needed?

CRST has devoted countless pages to optimizing the refractive outcome of cataract surgery. Contributors have shared their insights into managing astigmatism, honing nomograms, refining surgical techni…

Read the full story

Thursday, July 21, 2016 | Medical Studies

Florida, CDC Looking Into Possible First Homegrown Zika Case

Public health officials in Florida are investigating a laboratory-confirmed case of Zika infection in the Miami area that appears to be unrelated to travel, according to the Centers for Disease Contro…

Read the full story

Wednesday, July 20, 2016 | Medical Studies

Clinical Alert: HORV Association with Intraocular Vancomycin

Following the first published series of hemorrhagic occlusive retinal vasculitis (HORV) [1,2], the American Society of Cataract and Refractive Surgery (ASCRS) and the American Society of Retina Specia…

Read the full story

Tuesday, July 19, 2016 | Miscellaneous, Bausch+Lomb

Bausch + Lomb Provides Business Update for US Vision Care

Mark McKenna, Senior Vice President & General Manager, US Vision Care, Bausch + Lomb, released the following letter to eye care practitioners updating the company's commitment to work with the…

Read the full story

Tuesday, July 19, 2016 | Medical Studies

Report: Optical Imaging System Market to Reach $3 Billion by 2024

The global optical imaging system market is expected to reach $3 billion by 2024, according to a new report by Grand View Research. Technological advancements and rising preference for nonin…

Read the full story

Tuesday, July 19, 2016 | Acquisitions/Mergers, Glaucoma, InnFocus, Santen

Santen to Acquire InnFocus, Developer of MicroShunt Glaucoma Implant Device

Santen Pharmaceutical and InnFocus announced that the two companies have entered into a definitive agreement under which Santen will acquire privately held InnFocus, developer of the InnFocus MicroShu…

Read the full story

Tuesday, July 19, 2016 | FDA Approval/Clearance, Avedro

Avedro’s Cross-linking Platform Approved by FDA for Corneal Ectasia Following Refractive Surgery

Avedro has received approval from the FDA for its corneal collagen cross-linking platform for the treatment of corneal ectasia following refractive surgery. The approval marks the second indication fo…

Read the full story
Load More